CEO, TrustPlus
Founder and Managing Partner, Frazier Healthcare Ventures
Scientist and Managing Dir., Microsoft Research New England
Lecturer, Boston University School of Management
Prof. Dept. of Medicine/Hematology, Univ. of Washington
Dean, Division of Biological Sciences, UC San Diego
CEO and Founder, TechStars
Professor of Molecular Biology, Rockefeller University
|
One of the big dreams in biotech over the past 35 years has been to make drugs that work like “smart bombs” by destroying tumors while minimizing collateral damage. Scientists have learned this is no easy thing, but now that a couple... Read more »
Biotech firm Promedior announced today that it will be moving its headquarters from Malvern, PA, to Boston, and that it has hired a new CEO, Suzanne Bruhn,who was previously senior vice president for planning and program management for Shire’s Human Genetic Therapies division.... Read more »
Theraclone Sciences has taken its first step ahead toward showing it might have an antibody drug that could work in humans.
The Seattle-based biotech company is announcing today that it passed its first clinical trial with an antibody drug designed to fight... Read more »
Startup accelerators like Y Combinator and TechStars are known for producing the latest and greatest in Web startups. But there’s a set of established and accomplished companies—like ZipCar (NASDAQ: ZIP), Xenogen, and Constant Contact (NASDAQ: CTCT)—that also received startup coaching, mentoring,... Read more »
In March, global consulting firm Ernst & Young released an annual report for its life sciences clients called “The Third Place: Healthcare Everywhere.” It discusses a range of topics, from apps designed to improve patient adherence to medical treatments, to games that... Read more »
JumpStart Inc., a Cleveland-based nonprofit focused on entrepreneurship and economic development, will team with the New Economy Initiative (NEI) to open a new high-tech accelerator in Detroit, says NEI executive director David Egner. Egner (an Xconomist) says a variety of state and... Read more »
The pistons of the biggest publicity engine in cancer R&D will start firing this week. It’s time to behold the annual rite of the American Society of Clinical Oncology (ASCO) meeting, the biggest event for showing off what’s new... Read more »
CEO, Cambridge Innovation Center
Founder and International Chairman, Boston Power
Partner, Nixon Peabody LLP
CEO and Managing Partner, Flagship Ventures
President and CEO, PATH
Boston · 6/14/12
8:30 am - 5:00 pm
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
